Compounds > puromycin aminonucleoside

puromycin aminonucleoside and sirolimus

puromycin aminonucleoside has been researched along with sirolimus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axelsson, J; Rippe, A; Rippe, B1
He, Q; Hu, K; Jin, J; Wu, D; Ye, M1

Other Studies

2 other study(ies) available for puromycin aminonucleoside and sirolimus

ArticleYear
mTOR inhibition with temsirolimus causes acute increases in glomerular permeability, but inhibits the dynamic permeability actions of puromycin aminonucleoside.
    American journal of physiology. Renal physiology, 2015, May-15, Volume: 308, Issue:10

    Topics: Angiotensin II; Animals; Cell Membrane Permeability; Cyclic N-Oxides; Glomerular Filtration Rate; Kidney Glomerulus; Male; Models, Animal; Puromycin Aminonucleoside; Rats; Rats, Wistar; Sirolimus; Spin Labels; Time Factors; TOR Serine-Threonine Kinases

2015
Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and mTOR/ P70S6K/4EBP1 Signaling.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 48, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Autophagy; Carrier Proteins; Cell Cycle Proteins; Cell Line; Cell Proliferation; Eukaryotic Initiation Factors; Mice; Microtubule-Associated Proteins; Phosphoproteins; Podocytes; Puromycin Aminonucleoside; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2018